ATM and cancer: PTEN inactivation [20,21], mutations in PIK3R1 (which encodes p85α) that leading to constitutive activation of p110α [8,22,23] and ATM inactivation (through germ-line mutations [24], somatic ATM-inactivating mutations, deletions or epigenetic changes [25,26]) all predispose to cancer.